Unknown PHASE4 INTERVENTIONAL 1-arm NCT02321761

Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury

Sponsor: Loewenstein Hospital

Updated 9 times since 2017 Last updated: Aug 7, 2018 Started: Jun 30, 2014 Primary completion: Dec 1, 2018 Completion: Dec 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Traumatic Brain Injury, this trial is ongoing. The trial is conducted by Loewenstein Hospital and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Sep 2018 — Sep 2020 [monthly]

Recruiting PHASE4
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Loewenstein Hospital

Data source: Loewenstein Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Raanana, Israel